Fidelity Investments
OMGA

Fidelity Investments’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Fidelity Investments’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,924,846
Closed -$4.42M – 5782
2024
Q4 		$4.42M Sell
5,924,846
-137,258
-2% -$137K ﹤0.01% 2202
2024
Q3 		$7.4M Sell
6,062,104
-179,912
-3% -$286K ﹤0.01% 2019
2024
Q2 		$12.9M Sell
6,242,016
-51,141
-0.8% -$121K ﹤0.01% 1795
2024
Q1 		$23M Buy
6,293,157
+1,006,582
+19% +$3.86M ﹤0.01% 1600
2023
Q4 		$15.9M Buy
5,286,575
+92,473
+2% +$187K ﹤0.01% 1702
2023
Q3 		$11.2M Sell
5,194,102
-240,671
-4% -$962K ﹤0.01% 1796
2023
Q2 		$30.4M Buy
5,434,773
+17,114
+0.3% +$134K ﹤0.01% 1461
2023
Q1 		$32.7M Buy
5,417,659
+818,216
+18% +$5.7M ﹤0.01% 1414
2022
Q4 		$26.3M Sell
4,599,443
-4,260
-0.1% -$23.9K ﹤0.01% 1507
2022
Q3 		$25M Buy
4,603,703
+218,400
+5% +$1.11M ﹤0.01% 1540
2022
Q2 		$16.7M Sell
4,385,303
-273,203
-6% -$1.02M ﹤0.01% 1724
2022
Q1 		$29.1M Buy
4,658,506
+228,825
+5% +$2.34M ﹤0.01% 1614
2021
Q4 		$48.9M Buy
4,429,681
+228,500
+5% +$4.34M ﹤0.01% 1428
2021
Q3 		$75M Buy
+4,201,181
New +$80.6M 0.01% 1238

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Fidelity Investments's OMGA Position: Q1 2025 in Review

Fidelity Investments sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 5,924,846 shares — an estimated $4.42M sold.

Fidelity Investments first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $75M in Q3 2021. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Fidelity Investments reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 5,924,846 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $4.42M.
  • Fidelity Investments first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • Fidelity Investments's Omega Therapeutics, Inc. Common Stock position peaked at $75M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.